Nature Communications,
Год журнала:
2020,
Номер
11(1)
Опубликована: Фев. 5, 2020
Abstract
The
type
and
genomic
context
of
cancer
mutations
depend
on
their
causes.
These
causes
have
been
characterized
using
signatures
that
represent
mutation
types
co-occur
in
the
same
tumours.
However,
it
remains
unclear
how
processes
change
during
evolution
due
to
lack
reliable
methods
reconstruct
evolutionary
trajectories
mutational
signature
activity.
Here,
as
part
ICGC/TCGA
Pan-Cancer
Analysis
Whole
Genomes
(PCAWG)
Consortium,
which
aggregated
whole-genome
sequencing
data
from
2658
cancers
across
38
tumour
types,
we
present
TrackSig,
a
new
method
reconstructs
these
optimal,
joint
segmentation
deconvolution
allele
frequencies
single
sample.
In
simulations,
find
TrackSig
has
3–5%
activity
reconstruction
error,
12%
false
detection
rate.
It
outperforms
an
aggressive
baseline
situations
with
branching
evolution,
CNA
gain,
neutral
mutations.
Applied
tumours
permits
pan-cancer
insight
into
changes
processes.
Frontiers in Oncology,
Год журнала:
2023,
Номер
13
Опубликована: Фев. 7, 2023
Colorectal
cancer
(CRC)
has
the
third-highest
incidence
and
second-highest
mortality
rate
of
all
cancers
worldwide.
Early
diagnosis
screening
CRC
have
been
focus
research
in
this
field.
With
continuous
development
artificial
intelligence
(AI)
technology,
AI
advantages
many
aspects
CRC,
such
as
adenoma
screening,
genetic
testing,
prediction
tumor
metastasis.This
study
uses
bibliometrics
to
analyze
summarize
field's
history
current
status
research,
predict
future
directions.We
searched
SCIE
database
for
literature
on
AI.
The
documents
span
period
2002-2022.
we
used
data
these
papers,
authors,
countries,
institutions,
references.
Co-authorship,
co-citation,
co-occurrence
analysis
were
main
methods
analysis.
Citespace,
VOSviewer,
SCImago
Graphica
visualize
results.This
selected
1,531
articles
CRC.
China
published
a
maximum
number
580
U.S.
had
most
quality
publications,
boasting
an
average
citation
per
article
46.13.
Mori
Y
Ding
K
two
authors
with
highest
articles.
Scientific
Reports,
Cancers,
Frontiers
Oncology
are
widely
journals.
Institutions
from
occupy
top
9
positions
among
institutions.
We
found
that
field
mainly
focuses
colonoscopy-assisted
diagnosis,
imaging
histology,
pathology
examination.AI
is
currently
stage
good
prospects.
colonoscopy,
imageomics,
pathology.
However,
scope
applications
still
limited,
there
lack
inter-institutional
collaboration.
pervasiveness
technology
direction
housing
Cell Death and Differentiation,
Год журнала:
2019,
Номер
27(2), С. 725 - 741
Опубликована: Июль 8, 2019
Abstract
Exquisite
regulation
of
PI3K/AKT/mTORC1
signaling
is
essential
for
homeostatic
control
cell
growth,
proliferation,
and
survival.
Aberrant
activation
this
network
an
early
driver
many
sporadic
human
cancers.
Paradoxically,
sustained
hyperactivation
the
pathway
in
nontransformed
cells
results
cellular
senescence,
which
a
tumor-suppressive
mechanism
that
must
be
overcome
to
promote
malignant
transformation.
While
oncogene-induced
senescence
(OIS)
driven
by
excessive
RAS/ERK
has
been
well
studied,
little
known
about
mechanisms
underpinning
AKT-induced
(AIS)
response.
Here,
we
utilize
combination
transcriptome
metabolic
profiling
identify
key
signatures
required
maintain
AIS.
We
also
employ
whole
protein-coding
genome
RNAi
screen
AIS
escape,
validating
subset
novel
mediators
demonstrating
their
preferential
specificity
as
compared
with
OIS.
As
proof
concept
potential
exploit
network,
show
neurofibromin
1
(NF1)
upregulated
during
its
ability
suppress
facilitates
maintenance.
Furthermore,
depletion
NF1
enhances
transformation
p53-mutant
epithelial
expressing
activated
AKT,
while
overexpression
blocks
inducing
senescent-like
phenotype.
Together,
our
findings
reveal
mechanistic
insights
into
putative
regulators
can
potentially
targeted,
implications
new
therapeutic
options
treat
PI3K/AKT/mTORC1-driven
Nature Communications,
Год журнала:
2020,
Номер
11(1)
Опубликована: Фев. 5, 2020
Abstract
The
type
and
genomic
context
of
cancer
mutations
depend
on
their
causes.
These
causes
have
been
characterized
using
signatures
that
represent
mutation
types
co-occur
in
the
same
tumours.
However,
it
remains
unclear
how
processes
change
during
evolution
due
to
lack
reliable
methods
reconstruct
evolutionary
trajectories
mutational
signature
activity.
Here,
as
part
ICGC/TCGA
Pan-Cancer
Analysis
Whole
Genomes
(PCAWG)
Consortium,
which
aggregated
whole-genome
sequencing
data
from
2658
cancers
across
38
tumour
types,
we
present
TrackSig,
a
new
method
reconstructs
these
optimal,
joint
segmentation
deconvolution
allele
frequencies
single
sample.
In
simulations,
find
TrackSig
has
3–5%
activity
reconstruction
error,
12%
false
detection
rate.
It
outperforms
an
aggressive
baseline
situations
with
branching
evolution,
CNA
gain,
neutral
mutations.
Applied
tumours
permits
pan-cancer
insight
into
changes
processes.